Renal dysfunction independently predicts muscle mass loss in patients following liver transplantation
dc.contributor.author | Nguyen, Mimosa | |
dc.contributor.author | Mukaneza, Yvette | |
dc.contributor.author | Tremblay, Mélanie | |
dc.contributor.author | Huard, Geneviève | |
dc.contributor.author | Tang, An | |
dc.contributor.author | Rose, Christopher | |
dc.contributor.author | Bémeur, Chantal | |
dc.date.accessioned | 2022-05-10T12:27:45Z | |
dc.date.available | NO_RESTRICTION | fr |
dc.date.available | 2022-05-10T12:27:45Z | |
dc.date.issued | 2022-05-02 | |
dc.identifier.uri | http://hdl.handle.net/1866/26643 | |
dc.publisher | University of Toronto Press | fr |
dc.subject | Cirrhosis | fr |
dc.subject | Liver transplantation | fr |
dc.subject | Renal dysfunction | fr |
dc.subject | Sarcopenia | fr |
dc.title | Renal dysfunction independently predicts muscle mass loss in patients following liver transplantation | fr |
dc.type | Article | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine. Département de médecine | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine. Département de nutrition | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine. Département de radiologie, radio-oncologie et médecine nucléaire | fr |
dc.identifier.doi | 10.3138/canlivj-2021-0042 | |
dcterms.abstract | Liver transplantation (LT) is the only curative treatment for cirrhosis. However, the presence of complications can impact outcomes following LT. Sarcopenia, or muscle mass loss, is highly prevalent in patients with cirrhosis and is associated with longer hospitalization stays and a higher infection rate post-surgery. We aimed to identify patients at higher risk of early sarcopenia post-LT. METHODS: This retrospective study included 79 cirrhotic patients who underwent LT. Muscle mass was evaluated using the third lumbar spine vertebra skeletal muscle mass index (SMI) and sarcopenia was defined using established cut-off values. Computerized tomography (CT) scans performed within six-month peri-operative period (three months pre- and post-LT) were included in the study. Complications and comorbidities were collected and correlated to SMI post-LT and predictive models for SMI post-LT were constructed. RESULTS: The overall prevalence of sarcopenia was 46% and 62% before and after LT, respectively. Newly developed sarcopenia was found in 42% of patients. Post-LT sarcopenia was associated with longer hospital stays (54±37 vs 29±10 days, p = 0.002), higher number of infection (3±1 vs 1±2, p = 0.027), and greater number of complications (5±2 vs 3±2, p <0.001) compared to absence of sarcopenia. Multivariate analyses showed that the SMI post-LT was independently associated with pre-LT renal function markers, the glomerular filtration rate (GFR) and creatinine (Model 1, GFR: β = 0.33; 95% CI = 0.04–0.17; p = 0.003; Model 2, Creatinine: β = –0.29; 95% CI = –0.10 to –0.02; p = 0.009). CONCLUSIONS: The present study highlights the potential role of renal dysfunction in the development and persistence of sarcopenia after LT. | fr |
dcterms.isPartOf | urn:ISSN:2561-4444 | fr |
dcterms.language | eng | fr |
UdeM.ReferenceFournieParDeposant | 10.3138/canlivj-2021-0042 | fr |
UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | fr |
oaire.citationTitle | Canadian liver journal | fr |
Files in this item
This item appears in the following Collection(s)
This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.